President Duterte is standing firmly behind his men after the Office of the Ombudsman launched an investigation into the alleged irregularities in the Department of Health’s (DOH) coronavirus response.
President Rodrigo Roa Duterte holds a meeting with members of the Inter-Agency Task Force on the Emerging Infectious Diseases at the Malago Clubhouse in Malacañang on June 22, 2020. ALBERT ALCAIN/PRESIDENTIAL PHOTO
Duterte also said he is ready to put his reputation on the line as he assured that there was nothing anomalous in the government’s efforts to address the pandemic. “With due respect to the Ombudsman, the honorable Martires, iniimbestiga pa niya. Pero kung ako ang lang tanungin, kung ako ang imbestigahan niya, e di magpunta talaga ako at sabihin ko na I believe in the integrity and honesty of my people ,” the President said.In defending the integrity of his officials, Duterte recognized that public service requires sacrifice on the part of these government workers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Duterte tasks Cimatu to oversee COVID-19 response in CebuPresident Duterte has ordered Environment Secretary Roy Cimatu to fly to Cebu City and oversee the implementation of the measures against the COVID-19 pandemic and make recommendations on what should be done to contain the spread of the disease.
Read more »
Cops nab foreigner for selling illegal COVID-19 medicine in ParañaqueMANILA, Philippines — Police officers arrested a Chinese man in Parañaque City on Saturday afternoon for allegedly selling unregistered medicine that allegedly treats the coronavirus disease
Read more »
DOH to validate European study linking blood type to COVID-19 riskMANILA, Philippines — The Department of Health (DOH) is now gathering evidence that could corroborate a report from Europe that people with certain blood types are more susceptible to infection from
Read more »
132 BFP-Region 6 staff negatibo sa COVID-19
Read more »
Swiss giant Novartis halts COVID-19 hydroxychloroquine studyNot enough patients are enrolling in clinical trials
Read more »